International Cannabis Weekly: 406

CANNABIS EUROPA 2025: KEY INSIGHTS FROM DAY ONE

As London basked in one of the hottest days of the British summer so far, over 1,500 industry leaders converged at the Barbican Centre to kick off the final leg of European Cannabis Week 2025.

Despite being fresh off the plane from three days at the characteristically lively Mary Jane Berlin, the mood – much like the weather – remained bright and energetic as Cannabis Europa 2025 welcomed the world’s leading cannabis voices for its first jam packed day of sessions.

READ PART 1  »

READ PART 2  »

CANNABIS EUROPA 2025: KEY INSIGHTS FROM DAY TWO IN LONDON

READ MORE »

RESEARCH IS THE GATEWAY TO WIDER NHS ACCESS TO MEDICAL CANNABIS

READ MORE »

• London becomes the epicentre of the global cannabis industry for Cannabis Europa 2025.
• Bloom has revealed plans for an early 2026 UK launch with Garden Pharma partnership.
• Puro has secured lucrative AU$14.6 million medicinal cannabis export deal to Europe.
• Canadian firm Aurora has introduced two new high-potency cannabis flower strains in Poland.
• Dalgety has entered into strategic agreement with Curaleaf Laboratories for expansion.
• Tilray Medical has received Italy’s first authorisation to distribute medical cannabis.
• A new French report has highlighted some of the challenges in medical cannabis rollout.
• Glass Pharms has signed a new supply deal with Mamedica, boosting UK cannabis sector.
• Grow Group CEO, Ben Langley, has outlined vision for the UK’s cannabis future.
• Mary Jane Berlin 2025 draws a crowd of 65,000 as cannabis culture takes centre stage in Europe.

SEE THE WINNERS »